Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-111K18.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | MYOZ3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CLEC9A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | AMER1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | C14orf93 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CTBS | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | C7orf25 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | SPATA13 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
mRNA | PON2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | EAF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |